Therapeutic Value of Endoscopic and Laparoscopic Resection for Small Gastric Gastrointestinal Stromal Tumor Clinical Trial
— CELSGISTOfficial title:
Comparison of Endoscopic and Laparoscopic Resection for Small Gastric
Comparison of Endoscopic and Laparoscopic Resection for Small Gastric Gastrointestinal Stromal Tumor
Status | Recruiting |
Enrollment | 900 |
Est. completion date | December 31, 2021 |
Est. primary completion date | October 30, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - 18-70 years old Chinese; - Definite diagnosis or endoscopic ultrasonography, CT and other highly suspected Chinese patients with gastric stromal tumors; - Patients voluntarily signed informed consent and have been orally informed of the specific trial plan. Exclusion Criteria: - Patients with gastric stromal tumors with distant metastasis who cannot be treated by laparoscopic surgery; - Combined heart , cerebrovascular , liver , kidney , and hematopoietic system serious primary disease; - gastric stromal tumors with severe digestive tract hemorrhage endanger the immediate surgical treatment of life; - The investigator considers that it is not suitable for this test. |
Country | Name | City | State |
---|---|---|---|
China | Nanfang Hospistal | Guangzhou | Guangdong |
Lead Sponsor | Collaborator |
---|---|
Nanfang Hospital of Southern Medical University | Shenzhen Hospital of Southern Medical University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | recur or not in 2 years after endoscopic surgical procedure or surgery | Participants will be followed up for 2 years after endoscopic surgical procedure or surgery by endoscope and/or endoscopic ultrasonography. | 2 years after endoscopic surgical procedure or surgery |